Hollow Brook Wealth Management LLC reduced its holdings in shares of Procter & Gamble Company (The) (NYSE:PG - Free Report) by 51.5% in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 32,294 shares of the company's stock after selling 34,298 shares during the quarter. Procter & Gamble accounts for about 0.8% of Hollow Brook Wealth Management LLC's holdings, making the stock its 23rd biggest position. Hollow Brook Wealth Management LLC's holdings in Procter & Gamble were worth $4,692,000 as of its most recent SEC filing.
Other hedge funds and other institutional investors also recently made changes to their positions in the company. BlackRock Inc. bought a new position in Procter & Gamble in the 2nd quarter valued at about $27,862,105,000. Bank of America Corp DE acquired a new position in Procter & Gamble during the 2nd quarter valued at about $3,850,628,000. Bank of New York Mellon Corp bought a new stake in Procter & Gamble during the 2nd quarter worth approximately $2,281,505,000. Mitsubishi UFJ Asset Management Co. Ltd. bought a new stake in Procter & Gamble during the 2nd quarter worth approximately $1,480,650,000. Finally, Corient Private Wealth LP purchased a new stake in shares of Procter & Gamble in the second quarter worth approximately $335,908,000. 65.77% of the stock is owned by institutional investors.
Key Stories Impacting Procter & Gamble
Here are the key news stories impacting Procter & Gamble this week:
- Positive Sentiment: Analyst upgrade: Freedom Broker upgraded PG from “hold” to “buy,” providing a positive signal for the stock and reflecting greater confidence in the company’s outlook. Freedom Broker upgrades Procter & Gamble to buy from hold
- Positive Sentiment: Dividend appeal remains strong: Articles highlighted PG as a long-standing dividend leader, supporting its appeal to income-focused and defensive investors. The company’s record of dividend increases may help underpin demand for the shares, particularly when investors favor stable consumer-staples businesses. Dividend Kings article Trusted dividend stocks article
- Neutral Sentiment: Bond issuance adds balance-sheet context: PG’s euro- and dollar-denominated bond sale provides liquidity and funding flexibility, but it also draws attention to leverage, interest costs, and the company’s relatively elevated valuation. Procter & Gamble bond sale
- Neutral Sentiment: Growth story under review: Commentary on PG points to accelerating revenue growth, while also noting that higher operating costs could pressure margins and earnings. Investors are weighing improved sales momentum against cost inflation. Procter & Gamble revenue growth and costs What changed in Procter & Gamble’s story
- Negative Sentiment: Mixed rating signals and valuation risk: DZ Bank downgraded PG from “strong-buy” to “hold.” With shares trading at a premium valuation, a more cautious analyst stance could weigh on upside unless earnings growth accelerates. DZ Bank rating change
- Negative Sentiment: Advertising challenge produced only a limited win: Following PG’s challenge, the National Advertising Division supported Carpe’s $19.95 reference price but recommended changes or removal of other savings, free-shipping, comparative-performance, and “first” 100-hour protection claims. The outcome may modestly strengthen competitive advertising standards, but it does not represent a material financial catalyst for PG. National Advertising Division decision involving Carpe
Insider Transactions at Procter & Gamble
In other news, CEO Paul Gama sold 4,331 shares of the firm's stock in a transaction on Friday, October 23rd. The stock was sold at an average price of $161.27, for a total transaction of $698,460.37. Following the completion of the sale, the chief executive officer directly owned 46,793 shares of the company's stock, valued at $7,546,307.11. This trade represents a 8.47% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. Also, CFO Andre Schulten sold 3,914 shares of Procter & Gamble stock in a transaction on Monday, October 5th. The stock was sold at an average price of $145.34, for a total value of $568,860.76. Following the sale, the chief financial officer owned 65,618 shares in the company, valued at $9,536,920.12. The trade was a 5.63% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Over the last three months, insiders have sold 58,647 shares of company stock worth $9,268,508. Company insiders own 0.23% of the company's stock.
Analyst Ratings Changes
A number of research firms have recently weighed in on PG. Citigroup raised their target price on Procter & Gamble from $180.00 to $187.00 and gave the company a "buy" rating in a report on Friday, October 23rd. The Goldman Sachs Group reiterated a "neutral" rating and set a $161.00 price target on shares of Procter & Gamble in a report on Thursday, October 22nd. Weiss Ratings reissued a "hold (c)" rating on shares of Procter & Gamble in a research report on Monday, September 21st. JPMorgan Chase & Co. raised their price objective on Procter & Gamble from $162.00 to $180.00 and gave the company an "overweight" rating in a research note on Friday, October 23rd. Finally, Deutsche Bank Aktiengesellschaft reaffirmed a "buy" rating on shares of Procter & Gamble in a report on Friday, October 23rd. Fifteen analysts have rated the stock with a Buy rating and eleven have assigned a Hold rating to the stock. According to data from MarketBeat.com, the stock has an average rating of "Moderate Buy" and a consensus price target of $170.57.
Check Out Our Latest Research Report on PG
Procter & Gamble Price Performance
Shares of NYSE PG opened at $161.42 on Monday. The company has a market capitalization of $374.14 billion, a PE ratio of 24.31, a PEG ratio of 3.97 and a beta of 0.36. The company has a quick ratio of 0.53, a current ratio of 0.72 and a debt-to-equity ratio of 0.40. The stock's 50 day moving average price is $149.99 and its 200-day moving average price is $148.94. Procter & Gamble Company has a twelve month low of $137.62 and a twelve month high of $167.25.
Procter & Gamble (NYSE:PG - Get Free Report) last issued its quarterly earnings results on Thursday, October 22nd. The company reported $2.00 EPS for the quarter, beating analysts' consensus estimates of $1.89 by $0.11. The company had revenue of $23.28 billion during the quarter, compared to the consensus estimate of $22.80 billion. Procter & Gamble had a return on equity of 31.02% and a net margin of 18.23%. Procter & Gamble's revenue was up 4.0% on a year-over-year basis. During the same period last year, the business posted $1.99 earnings per share. On average, equities analysts anticipate that Procter & Gamble Company will post 6.99 EPS for the current year.
Procter & Gamble Dividend Announcement
The firm also recently disclosed a quarterly dividend, which will be paid on Monday, November 16th. Shareholders of record on Friday, October 23rd will be paid a $1.0885 dividend. This represents a $4.35 dividend on an annualized basis and a yield of 2.7%. The ex-dividend date is Friday, October 23rd. Procter & Gamble's dividend payout ratio is 65.51%.
Procter & Gamble Company Profile
(
Free Report)
Procter & Gamble Company NYSE: PG is a global consumer products company that develops, manufactures and markets branded products used in households and personal care. Its portfolio includes personal health and grooming products, beauty and skin care items, baby, feminine and family care products, fabric and home care products, and oral care products.
The company's well-known brands include Pampers, Tide, Gillette, Crest, Oral-B, Head & Shoulders, Pantene, Olay, Old Spice, Dawn, Febreze and Mr.
Read More

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Procter & Gamble, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Procter & Gamble wasn't on the list.
While Procter & Gamble currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2026. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.
Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.